Hydrocortisone is a short-acting glucocorticoid with extremely wide clinical applications, and it is also one of the core hormones naturally secreted by the human adrenal cortex. Compared with synthetic hormones, it features moderate pharmacological activity and high adaptability. It can not only simulate the body's own hormones to regulate physiological functions, but also exert pharmacological effects including anti-inflammatory, anti-allergic and anti-shock effects via exogenous supplementation. Thanks to its unique pharmacological advantages, hydrocortisone is widely used in multiple departments such as internal medicine, surgery, dermatology and emergency medicine. It is a fundamental drug for clinical management of a variety of acute critical illnesses as well as chronic inflammatory and immune-mediated diseases. This article systematically describes its specific clinical indications, and comprehensively reviews its medicinal value by combining applicable scenarios and medication characteristics.
I. Replacement Therapy: Correcting Adrenocortical Dysfunction
The most fundamental and original application of hydrocortisone lies in adrenocortical replacement therapy. It is the first-line drug for diseases caused by insufficient endogenous hormone secretion. Hydrocortisone secreted by the human adrenal cortex participates in the regulation of carbohydrate, protein, fat metabolism and water-salt balance. Impaired gland function may trigger a series of manifestations including metabolic disorders, reduced immunity and general fatigue.
Clinically, it is mainly indicated for primary and secondary adrenocortical insufficiency, including chronic adrenocortical failure, hormone replacement after adrenalectomy, and hormone deficiency induced by hypopituitarism. Meanwhile, intravenous infusion of hydrocortisone serves as a core rescue measure for life-threatening adrenal crisis. It rapidly compensates for hormone deficiency in vivo, corrects critical symptoms such as electrolyte disturbance, collapse and shock, and stabilizes patients' vital signs. In addition, long-term low-dose hydrocortisone administration for congenital adrenal hyperplasia suppresses abnormal hormone secretion, maintains metabolic homeostasis and supports normal growth and development of patients.
II. Anti-inflammatory Therapy: Alleviating Systemic Inflammatory Lesions
Potent yet moderate anti-inflammatory activity represents the core clinical value of hydrocortisone. It inhibits the whole cascade of inflammatory responses in the body, relieves inflammation-induced erythema, exudation, hyperplasia and tissue injury, and is applicable to inflammatory disorders of multiple systemic organs. Compared with long-acting glucocorticoids, hydrocortisone produces fewer adverse effects, making it more suitable for long-term management of routine inflammation and control of acute inflammatory episodes.
In the field of rheumatology and immunology, it is used for autoimmune inflammations such as rheumatoid arthritis, systemic lupus erythematosus and rheumatic myocarditis, rapidly alleviating joint swelling-pain and organ inflammatory damage to halt disease progression. For respiratory disorders, it provides adjuvant treatment for severe bronchial asthma and asthmatic bronchitis by mitigating congestion and edema of airway mucosa, relieving airway spasm and improving dyspnea. Furthermore, for severe bacterial and viral inflammation such as severe pneumonia and peritonitis, combined administration with sufficient anti-infective agents reduces inflammatory exudation, prevents tissue adhesion and attenuates organ damage caused by inflammation.
III. Anti-allergy and Immunosuppression: Management of Allergic Diseases
Hydrocortisone suppresses aberrant immune responses, reduces release of allergic mediators and lowers tissue reactivity to allergens. It is a key agent for clinical management of severe allergic disorders. For severe allergic symptoms uncontrolled by conventional anti-allergic drugs, hydrocortisone acts rapidly to block the progression of allergic reactions.
Clinically, it is employed to treat severe drug hypersensitivity, transfusion reactions, severe urticaria, allergic dermatitis and other conditions. Particularly for anaphylactic shock, intravenous hydrocortisone administered on the basis of epinephrine resuscitation sustains therapeutic effects, prevents recurrence of allergic manifestations, and relieves life-threatening presentations including laryngeal edema, hypotension and altered mental status. Moreover, for immune-mediated disorders such as autoimmune hemolysis and immune thrombocytopenic purpura, hydrocortisone inhibits dysregulated immune responses and decreases blood cell destruction to achieve therapeutic outcomes.
IV. Anti-shock and Emergency Resuscitation: Sustaining Vital Functions of Critically-ill Patients
Hydrocortisone exerts potent anti-shock effects by improving microcirculation, enhancing myocardial contractility, stabilizing cell membranes and mitigating tissue edema. It is indicated for adjuvant resuscitation of various types of shock and ranks among essential drugs in emergency departments. Applicable shock categories include infectious-toxic shock, anaphylactic shock, traumatic shock and hemorrhagic shock.
In the management of infectious-toxic shock, hydrocortisone suppresses excessive inflammatory responses triggered by endotoxins, corrects microcirculatory disturbance, elevates blood pressure and reduces the risk of multiple-organ failure. For shock secondary to severe trauma and massive hemorrhage, it alleviates stress-related injury and stabilizes internal environment, buying time for definitive interventions such as fluid resuscitation and hemostasis. Additionally, for critical conditions complicated by cerebral edema and intracranial hypertension, hydrocortisone reduces brain tissue swelling, lowers intracranial pressure, protects neurological function and saves patients' lives.
V. Topical Administration: Treatment of Cutaneous and Mucosal Disorders
Apart from systemic formulations, hydrocortisone creams and ointments are widely adopted in dermatology. With local anti-inflammatory, antipruritic and anti-allergic properties, they treat numerous skin diseases with minimal systemic adverse effects and satisfactory safety profiles.
They are mainly used for common dermatoses including allergic dermatitis, eczema, neurodermatitis, seborrheic dermatitis and insect-bite dermatitis, rapidly relieving pruritus, erythema, papules and exudation. They can also be applied for mild inflammation and allergic reactions of mucous membranes such as vulvar and perianal regions to ameliorate local discomfort. It should be noted that topical preparations shall be used in a standardized manner; long-term and extensive application should be avoided to prevent mild adverse reactions such as skin atrophy and pigmentation.
VI. Summary and Medication Principles
To sum up, the clinical indications of hydrocortisone cover five core domains: hormone replacement, anti-inflammation, anti-allergy, anti-shock and topical therapy. It is an irreplaceable fundamental glucocorticoid spanning mild-condition management to critical-illness resuscitation. Nevertheless, it is a prescription drug with definite contraindications and adverse effects. Long-term or excessive administration may give rise to osteoporosis, hyperglycemia, gastrointestinal injury and other complications. Therefore, clinical application shall strictly follow medical advice. Dosage and treatment course should be adjusted according to disease category and severity. Blind medication must be prohibited to maximize therapeutic efficacy while guaranteeing drug safety.
